Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

OncoCyte Corp (OCX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow OncoCyte's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.455 -0.055    -2.19%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
2.410
-0.045
-1.833%
17:37:07 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 22,677
  • Bid/Ask: 2.250 / 2.660
  • Day's Range: 2.450 - 2.553
OncoCyte 2.455 -0.055 -2.19%

OncoCyte Corp Company Profile

 
Get an in-depth profile of OncoCyte Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

45

Equity Type

ORD

OncoCyte Corporation, a precision diagnostics company, focuses on development and commercialization of proprietary tests in the United States and internationally. The company is developing DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies; DetermaCNI, a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients; and VitaGraft, a blood-based solid organ transplantation monitoring test. It also provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. (Bio-Rad) to collaborate in the development and the commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad’s ddPCR instruments and reagents. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

Contact Information

Address 15 Cushing
Irvine, 92618
United States
Phone 949 409 7600
Fax -

Top Executives

Name Age Since Title
Andrew Arno 63 2015 Independent Chairman
Joshua Riggs - 2022 President, CEO & Director
Alfred D. Kingsley 80 2009 Independent Director
Ignacio I. Wistuba - 2021 Member of Scientific & Medical Advisory Board
David R. Gandara 75 - Member of Scientific & Medical Advisory Board
Daniel F. Hayes - 2021 Member of Scientific & Medical Advisory Board
Andrew J. Last 63 2015 Independent Director
Fred R. Hirsch - 2021 Member of Scientific & Medical Advisory Board
John M. Kirkwood - 2021 Member of Scientific & Medical Advisory Board
Heinz-Josef Lenz 63 2021 Member of Scientific & Medical Advisory Board
Robert L. Ferris - - Member of Scientific & Medical Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OCX Comments

Write your thoughts about OncoCyte Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Marielle Velasco
Marielle Velasco Dec 17, 2020 6:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Where is thus going
Tariq Matloob
Tariq Matloob Dec 16, 2020 7:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Oncocyte Soars on Licensing Deal With Chinese FirmThe cancer detection company said it has licensed a lung cancer test to China’s Burning Rock Biotech.DAN WEIL20 HOURS AGO
Sebastian Melin
Sebastian Melin Dec 15, 2020 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
just stopped dead in its tracks? :(
Brijesh Patel
Brijesh Patel Dec 15, 2020 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yeah it did
Khalil Borashed
Khalil Borashed Oct 01, 2020 9:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
estimates have projected may approach $15 billion by 2025. yahoo finace the source
Khalil Borashed
Khalil Borashed Oct 01, 2020 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The agreement will allow Oncocyte to increase its test portfolio in the U.S. to address a broader care continuum.
Kelly Robinson
Kelly Robinson Feb 26, 2020 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
one if the most inactive stocks. we would like some positive news.
Ramiro Marrero
Ramiro Marrero Jun 25, 2019 7:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any news expected soon? What are the future potential of this company. I am considering buy 1k shares? Thanks
Sean Mabingnay
Sean Mabingnay Jan 29, 2019 2:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
to God be the glory
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email